Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$8.26 USD
-0.25 (-2.94%)
Updated Jun 17, 2024 04:00 PM ET
After-Market: $8.28 +0.02 (0.24%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 41 - 60 ( 146 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
VY-AADC/NBIb-1817 Hits The Pause Button As DSMB Conducts Safety Review
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Hold On - FDA Issues Clinical Hold for VY-HTT01 in HD
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
CNS - Gene Therapy Panel; VY-AADC KOL Call Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Worth The Wait; Encouraging VY-AADC 2-/3-Year Update Puts Durability On Display
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
HEALTHCARE - The Week Ahead in Life SciencesThis report contains brief updates on the following: BMRN, VYGR, AQST, AXLA, ICPT, IMUX, VRNA, BPMC, MGNX. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
2Q20 Update; In a Much-Needed Boost the HD Program Gets the Internal Green Light
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
A Lot Riding on the 2Q20 Update on August 10; Target Lowered to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Change in Strategy But Not Vision For VYGR; Unwinding
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
PD Trial Enrollment Grinds to a Halt in the Wake of COVID
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Looking Ahead to ASGCT And Mid-Year Updates; In-Line 1Q20 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Onward! RESTORE Amendments Arrive, Pipeline Advancing
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L